89-114-334

F12, Sheep, Polyclonal Antibody, Abnova™

Manufacturer: Abnova Corporation

Select a Size

Pack Size SKU Availability Price
Each of 1 89-114-334-Each-of-1 In Stock ₹ 53,133.00

89-114-334 - Each of 1

₹ 53,133.00

In Stock

Quantity

1

Base Price: ₹ 53,133.00

GST (18%): ₹ 9,563.94

Total Price: ₹ 62,696.94

Antigen

F12

Classification

Polyclonal

Description

Sheep polyclonal antibody raised against native F12.

Formulation

In PBS (50% glycerol)

Gene Alias

HAE3/HAEX/HAF

Host Species

Sheep

Quantity

1 mg

Primary or Secondary

Primary

Test Specificity

This antibody recognizes human factor XII.

Content And Storage

Store at -20°C.Aliquot to avoid repeated freezing and thawing.

Applications

ELISA, Western Blot

Conjugate

Unconjugated

Dilution

Western Blot (25 ug/mL) The optimal working dilution should be determined by the end user.

Gene

F12

Gene Symbols

F12

Immunogen

Native purified Human F12.

Regulatory Status

RUO

Gene ID (Entrez)

2161

Target Species

Human

Form

Liquid

Related Products

Img

Abnova Corporation

89-114-341

--

Img

Abnova Corporation

89-114-336

--

Img

Abnova Corporation

89-114-330

--

Img

Abnova Corporation

89-114-338

--

Img

Abnova Corporation

89-118-841

--

Img

Abnova Corporation

89-137-756

--

Img

Abnova Corporation

89-139-146

--

Img

Abnova Corporation

89-139-141

--

Description

  • This gene encodes coagulation factor XII which circulates in blood as a zymogen
  • This single chain zymogen is converted to a two-chain serine protease with an heavy chain (alpha-factor XIIa) and a light chain
  • The heavy chain contains two fibronectin-type domains, two epidermal growth factor (EGF)-like domains, a kringle domain and a proline-rich domain, whereas the light chain contains only a catalytic domain
  • On activation, further cleavages takes place in the heavy chain, resulting in the production of beta-factor XIIa light chain and the alpha-factor XIIa light chain becomes beta-factor XIIa heavy chain
  • Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then to beta-factor XIIa
  • The active factor XIIa participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin
  • It activates coagulation factors VII and XI
  • Defects in this gene do not cause any clinical symptoms and the sole effect is that whole-blood clotting time is prolonged
  • [provided by RefSeq